Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimfirst M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sinsan Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimfirst M 1mg/500mg Tablet

Diabetam Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetam Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is vital, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, lightheadedness, headache, and tremors. Knowing these signs and carrying readily-available glucose (e.g., sugary snacks, juice) is crucial. Alcohol consumption elevates hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are necessary.

Uses of Glimfirst M 1mg/500mg Tablet

Managing Type 2 diabetes

Major Benefits of Glimfirst M 1mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimfirst M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Glimfirst M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimfirst M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Glimfirst M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Glimfirst M 1mg/500mg Tablet works:

Glimfirst M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimfirst M 1mg/500mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimfirst M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimfirst M 1mg/500mg tablets are incompatible; evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimfirst M 1mg/500mg tablets, potentially requiring dosage modification. Physician consultation is recommended. Glimfirst M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimfirst M 1mg/500mg tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimfirst M 1mg/500mg Tablet :

Should you forget a dose of Glimfirst M 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimfirst M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimfirst M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimfirst M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimfirst M 1mg/500mg and seek immediate medical attention.
Glimfirst M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimfirst M 1mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimfirst M 1mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimfirst M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimfirst M 1mg/500mg tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimfirst M 1mg/500mg Tab...
66
MRP 80
17% off